University of Connecticut University of UC Title Fallback Connecticut

Ashley Kalinauskas, '14 (BUS). (Nathan Oldham/UConn School of Business)

Drug Triggers Immune System to Fight Cancer in Pets

Ashley Kalinauskas, '14 (BUS). (Nathan Oldham/UConn School of Business)
Ashley Kalinauskas, ’14 (BUS). (Nathan Oldham/UConn School of Business)

UConn Today – Every time the veterinarian removed the cancerous tumor from the back of “BW,” a sweet-faced, well-loved, white cat, the malignancy would return two or three weeks later.

The cat’s owner opted to try a revolutionary veterinary cancer treatment, called VetiVax, which triggers the animal’s immune system to fight the disease. After the third treatment, the fibrosarcoma tumor didn’t recur, and “BW” has been healthy for 2½ years.

UConn alumna Ashley Kalinauskas is the CEO of Torigen Pharmaceuticals, the Farmington, Connecticut-based company that creates the new treatment. She is currently marketing it to veterinarians and is anticipating rapid growth for her startup.

Operations and Information Management Pressroom

Upcoming Events

  1. This calendar has no events scheduled at this time.

Read More

Feature stories:

Research:

Media Mentions:

Quick Links

Website

Contact

Media Contact

For all media inquiries, please contact:

Michael J. Deotte
Communications Director
+1 (860) 486-4478
mdeotte@business.uconn.edu

UConn faculty are available for live interviews from the campus television studio.